Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186,164,820
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
57,426,011
-
Shares change
-
+3,279,530
-
Total reported value, excl. options
-
$2,273,517,142
-
Value change
-
+$133,648,027
-
Number of buys
-
73
-
Number of sells
-
-33
-
Price
-
$39.59
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2020
129 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q4 2020.
Revolution Medicines, Inc. - Common Stock (RVMD) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57,426,011 shares
of 186,164,820 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include FMR LLC (9,339,485 shares), TRV GP III, LLC (7,024,031 shares), VANGUARD GROUP INC (4,037,820 shares), Column Group LLC (3,580,252 shares), BlackRock Inc. (3,512,087 shares), BOXER CAPITAL, LLC (3,309,264 shares), BVF INC/IL (2,768,049 shares), Cormorant Asset Management, LP (2,495,066 shares), TRV GP II, LLC (1,909,317 shares), and STATE STREET CORP (1,791,132 shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.